CapitolRadar tracks every publicly disclosed SYK trade by US congress members and corporate insiders: 52 disclosed trades (30 buys, 22 sells) by 3 tracked traders, from 2022-01-11 to 2026-09-25. Updated daily from official filings.
Want a ping when Congress buys SYK? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Stryker Corporation (SYK) — Healthcare · Medical - Devices, market cap about $108.0B.
CapitolRadar analysis
52 disclosed trades, with buys ahead 30 to 22
52 tracked SYK trades were disclosed by three distinct traders from January 11, 2022 through September 25, 2026. The activity comprised 30 buys and 22 sells, giving purchases a modest numerical majority. The sample remains small, however, with only three traders represented, so the totals do not describe broad congressional participation in Stryker Corporation, a Healthcare / Medical - Devices company.
28 of the 30 buys were attributed to Ro Khanna, whose latest listed purchase occurred on September 4, 2026. Jared Moskowitz accounted for the other two buys, most recently on April 7, 2025. This means all reported purchases came from just two people, and one trader supplied nearly all of them. The provided data does not identify the third trader’s individual transactions.
5 trades in 2026 Q3, but only one was a buy
2026 Q3 recorded five trades, including one buy and therefore four sells. That is the highest count among the quarterly snapshots supplied. Both 2026 Q2 and Q1 had one trade: Q2’s was a buy, while Q1’s was not. The listed 2025 quarters each contained one trade, with buys in Q2 and Q1 and a non-buy in Q4. For 2024, Q4 had one buy and Q3 had one non-buy. Because several quarters are not included in the supplied breakdown, no conclusion can be drawn about activity in those omitted periods.
2 buyers overlapped in HCA, HD, META and MSFT
Both identified SYK buyers also purchased HCA, HD, META and MSFT. One of the two also bought ADI, and one also bought APO; the data does not specify which buyer made those purchases. These overlaps show shared disclosed holdings activity, not a stated strategy or motive.
Congressional disclosures can appear up to 45 days after a transaction, so reported dates may lag the underlying trade. Disclosure amount ranges, when reported, are estimates rather than exact transaction values; no amount ranges were provided here. The limited trader count and sparse quarterly samples also restrict broader interpretation.
Analysis written from the tracked record on 2026-10-13; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 5 | 1 | 4 |
| 2026 Q2 | 1 | 1 | 0 |
| 2026 Q1 | 1 | 0 | 1 |
| 2025 Q4 | 1 | 0 | 1 |
| 2025 Q2 | 1 | 1 | 0 |
| 2025 Q1 | 1 | 1 | 0 |
| 2024 Q4 | 1 | 1 | 0 |
| 2024 Q3 | 1 | 0 | 1 |
Who is buying SYK?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 28 | 2026-09-04 | — |
| Jared Moskowitz | 2 | 2025-04-07 | — |
Disclosed trades in SYK
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-09-11 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2026-09-04 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-07-22 | Thomas H. Kean | sell | $1,001 - $15,000 | — |
| 2026-07-22 | Thomas H. Kean | sell | $1,001 - $15,000 | — |
| 2026-04-13 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2026-01-29 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2025-10-07 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-04-07 | Jared Moskowitz | buy | $1,001 - $15,000 | — |
| 2025-01-15 | Jared Moskowitz | buy | $1,001 - $15,000 | — |
| 2024-10-14 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-09-13 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2024-03-22 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2024-01-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-01-03 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-11-03 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-31 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2023-10-17 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-10 | Ro Khanna | sell | $50,001 - $100,000 | — |
| 2023-10-02 | Ro Khanna | sell | $15,001 - $50,000 | — |
These buyers also bought
Other stocks the tracked buyers of SYK disclosed buying in the last six months: HCA (2) · HD (2) · META (2) · MSFT (2) · ADI (1) · APO (1).
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive…
Frequently asked questions
Which politicians bought SYK most?
Ro Khanna leads with 28 disclosed buys, followed by Jared Moskowitz.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.